Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PASG
$4.01
+0.25%
PASG
· Passage BIO, Inc.
$4.01
+0.01 (+0.25%)
At close · Nov 12
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$12.90M
Shares
3.22M
Volume · Nov 12
12.63K
Avg daily vol (3M)
20.62K
All webcasts
Earnings call · FY2023 Q2
Passage BIO, Inc. (PASG) Q2 2023 Earnings Call
Diluted EPS
-$8.80
Net income
-$23.86M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2023 · complete as-filed document